Cargando…

Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease

Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progr...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Gonçalo, Ribeiro-Silva, Cristina, Ribeiro, Raquel, Gilberto, Samuel, Gomes, Ricardo A., Ferreira, António, Mateus, Élia, Barroso, Eduardo, Coelho, Ana V., Freire, Ana Ponces, Cordeiro, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492746/
https://www.ncbi.nlm.nih.gov/pubmed/26147092
http://dx.doi.org/10.1371/journal.pone.0125392
_version_ 1782379811590635520
author da Costa, Gonçalo
Ribeiro-Silva, Cristina
Ribeiro, Raquel
Gilberto, Samuel
Gomes, Ricardo A.
Ferreira, António
Mateus, Élia
Barroso, Eduardo
Coelho, Ana V.
Freire, Ana Ponces
Cordeiro, Carlos
author_facet da Costa, Gonçalo
Ribeiro-Silva, Cristina
Ribeiro, Raquel
Gilberto, Samuel
Gomes, Ricardo A.
Ferreira, António
Mateus, Élia
Barroso, Eduardo
Coelho, Ana V.
Freire, Ana Ponces
Cordeiro, Carlos
author_sort da Costa, Gonçalo
collection PubMed
description Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.
format Online
Article
Text
id pubmed-4492746
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44927462015-07-15 Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease da Costa, Gonçalo Ribeiro-Silva, Cristina Ribeiro, Raquel Gilberto, Samuel Gomes, Ricardo A. Ferreira, António Mateus, Élia Barroso, Eduardo Coelho, Ana V. Freire, Ana Ponces Cordeiro, Carlos PLoS One Research Article Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis. Public Library of Science 2015-07-06 /pmc/articles/PMC4492746/ /pubmed/26147092 http://dx.doi.org/10.1371/journal.pone.0125392 Text en © 2015 da Costa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
da Costa, Gonçalo
Ribeiro-Silva, Cristina
Ribeiro, Raquel
Gilberto, Samuel
Gomes, Ricardo A.
Ferreira, António
Mateus, Élia
Barroso, Eduardo
Coelho, Ana V.
Freire, Ana Ponces
Cordeiro, Carlos
Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title_full Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title_fullStr Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title_full_unstemmed Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title_short Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease
title_sort transthyretin amyloidosis: chaperone concentration changes and increased proteolysis in the pathway to disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492746/
https://www.ncbi.nlm.nih.gov/pubmed/26147092
http://dx.doi.org/10.1371/journal.pone.0125392
work_keys_str_mv AT dacostagoncalo transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT ribeirosilvacristina transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT ribeiroraquel transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT gilbertosamuel transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT gomesricardoa transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT ferreiraantonio transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT mateuselia transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT barrosoeduardo transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT coelhoanav transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT freireanaponces transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT cordeirocarlos transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease